mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.4 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.4 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.4 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.4 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.4 |